Article | September 11, 2026

QHP Capital Takes Novel Approach To Private Equity Investing In Life Sciences

By Kyle Marshall, NCBiotech

Private equity is often associated with aggressive cost-cutting and quick exits, but QHP Capital takes a different approach. The Raleigh-based life sciences investment firm partners with midsize, founder-led companies to strengthen leadership, operating processes, and accountability while pursuing sustainable revenue and profitability. Its management system turns strategy into focused operating plans, clear responsibilities, and a limited set of measurable goals. Portfolio companies such as Azurity Pharmaceuticals and Lexitas demonstrate how this model can help businesses scale while building the capabilities needed for long-term success. Rooted in North Carolina’s pharmaceutical services sector, QHP also brings experienced operators and industry relationships to companies at critical stages of growth.

Learn how this partnership-driven strategy is creating value for businesses and strengthening the state’s broader life sciences ecosystem.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

North Carolina Biotechnology Center